Baudax Bio, Inc.·4

Jun 17, 4:10 PM ET

HENWOOD GERALDINE 4

4 · Baudax Bio, Inc. · Filed Jun 17, 2022

Insider Transaction Report

Form 4
Period: 2022-06-15
HENWOOD GERALDINE
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2022-06-15+39,47349,093 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    571
Footnotes (1)
  • [F1]Each Restricted Stock Unit ("RSU") is the economic equivalent of one share of Baudax Bio, Inc. (the "Company") common stock, and may be settled, at the Company's option, in cash, shares of common stock, or a combination thereof. The RSUs vest 50% on June 15, 2023 and 50% on June 15, 2024, in each case subject to continued service with the Company through the applicable vesting date. Upon vesting, if settled in cash, each RSU will entitle the grantee to a cash-payment equal to the "Fair Market Value" (as defined in the Company's 2019 Equity Incentive Plan) of one share of the Company's common stock on the applicable vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES